Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04783168 · ClinicalTrials.gov registry record · NA
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
A NA study of Lung Carcinoma, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT04783168: Recruiting NA study of Lung Carcinoma, sponsored by M.D. Anderson Cancer Center.
NCT04783168 is a NA study of Lung Carcinoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 240 participants, below the 5,037-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04783168, a NA study of Lung Carcinoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates the relationship between walking and sleeping habits and surgical outcomes in patients with lung cancer. Early walking after surgery is associated with decreased or less severe complications. Learning about how much patients walk may be important in improving outcomes after surgery. Information gained from this trial may help researchers develop interventions to improve outcomes after surgery and improve overall quality of life after surgery in patients with lung cancer.
Primary Outcome
Two Bayesian probability and inferential models will be utilized: * Model 1: Inferential goals: Probability that POM score in the control arm is greater than F0 or FB arm: mean and 95% Credible Interval * Model 2: Baseline covariates adjusted analysis of model 1 * Performance status * FEV1 * Age * Open vs. Minimally invasive (0 is best, 5 is worst.) 0 - No postoperative complications 1. - Minor complication resolved without intervention 2. - complication requiring pharmaceutical interv
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Medical Device Usage and Evaluation
- OTHER Best Practice
- OTHER Health Promotion and Education
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2020-11-30 |
| Est. Completion | 2027-02-02 |
| Phase | NA |
What NCT04783168 shows while recruiting
NCT04783168 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 5,037-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Lung Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04783168 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04783168 about?
NCT04783168 is a clinical study titled "Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study". This clinical trial evaluates the relationship between walking and sleeping habits and surgical outcomes in patients with lung cancer. Early walking after surgery is associated with decreased or less severe complications. Learning about how much patients walk may be important in improving outcomes a...
What is the current status of trial NCT04783168?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2020-11-30. Estimated completion is 2027-02-02.
What conditions does trial NCT04783168 study?
This clinical trial studies the following conditions: Lung Carcinoma.
What interventions are being tested in trial NCT04783168?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Medical Device Usage and Evaluation (OTHER), Best Practice (OTHER), Health Promotion and Education (OTHER).
Who is sponsoring clinical trial NCT04783168?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04783168 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04783168's enrollment target sits among peer trials
240 14th of 38 higher than 25 of 38 other Lung Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
RECRUITING · NA
-
CONNECTing to LungCare
RECRUITING · NA
-
Engagement of Veterans With Lung Cancer
RECRUITING · NA
-
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
RECRUITING · NA
-
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI